Literature DB >> 18619417

Different inhibitory response of cyanidin and methylene blue for filament formation of tau microtubule-binding domain.

Masaki Hattori1, Etsuko Sugino, Katsuhiko Minoura, Yasuko In, Miho Sumida, Taizo Taniguchi, Koji Tomoo, Toshimasa Ishida.   

Abstract

One of the priorities in Alzheimer research is to develop a compound that inhibits the filament formation of tau protein. Since the three- or four-repeat microtubule-binding domain (MBD) in tau protein plays an essential role in filament formation, the inhibitory behavior of cyanidin (Cy) and methylene blue (MB) with respect to heparin-induced filament formation of MBD in a neutral solution (pH 7.6) was characterized by fluorescence, circular dichroism, and electron microscopy measurements. The planar aromatic ring of Cy and the N-unsubstituted phenothiazine ring of MB were shown to be necessary for the inhibition. However, the inhibitory responses with respect to heparin-induced filament formation to the second and third repeat peptides of MBD were different: Cy suppresses the formation and MB does not prevent the formation. This suggests the importance of the first and fourth repeat peptides in the inhibitory activity of MB for MBD filament formation. In this study, we showed that the decrease of thioflavin S fluorescence intensity is not always linked to inhibition of filament formation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18619417     DOI: 10.1016/j.bbrc.2008.07.001

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

Review 1.  From Mitochondrial Function to Neuroprotection-an Emerging Role for Methylene Blue.

Authors:  Donovan Tucker; Yujiao Lu; Quanguang Zhang
Journal:  Mol Neurobiol       Date:  2017-08-24       Impact factor: 5.590

Review 2.  FTD and ALS: a tale of two diseases.

Authors:  R Ferrari; D Kapogiannis; E D Huey; P Momeni
Journal:  Curr Alzheimer Res       Date:  2011-05       Impact factor: 3.498

Review 3.  Cellular and molecular actions of Methylene Blue in the nervous system.

Authors:  Murat Oz; Dietrich E Lorke; Mohammed Hasan; George A Petroianu
Journal:  Med Res Rev       Date:  2011-01       Impact factor: 12.944

Review 4.  Tau as a therapeutic target in neurodegenerative disease.

Authors:  Diana S Himmelstein; Sarah M Ward; Jody K Lancia; Kristina R Patterson; Lester I Binder
Journal:  Pharmacol Ther       Date:  2012-07-10       Impact factor: 12.310

5.  Phenotypic identification of the redox dye methylene blue as an antagonist of heat shock response gene expression in metastatic melanoma cells.

Authors:  Angela L Davis; Christopher M Cabello; Shuxi Qiao; Sara Azimian; Georg T Wondrak
Journal:  Int J Mol Sci       Date:  2013-02-19       Impact factor: 5.923

6.  A Small Molecule Impedes Insulin Fibrillation: Another New Role of Phenothiazine Derivatives.

Authors:  Meghomukta Mukherjee; Jagannath Jana; Subhrangsu Chatterjee
Journal:  ChemistryOpen       Date:  2017-12-07       Impact factor: 2.911

Review 7.  Mitochondria as a target for neuroprotection: role of methylene blue and photobiomodulation.

Authors:  Luodan Yang; Hannah Youngblood; Chongyun Wu; Quanguang Zhang
Journal:  Transl Neurodegener       Date:  2020-06-01       Impact factor: 8.014

8.  IAPP aggregation and cellular toxicity are inhibited by 1,2,3,4,6-penta-O-galloyl-β-D-glucose.

Authors:  Edward Bruno; Catalina Pereira; Karla P Roman; Marisa Takiguchi; Pei-Yu Kao; Luiza A Nogaj; David A Moffet
Journal:  Amyloid       Date:  2013-01-22       Impact factor: 6.571

9.  Methylene Blue Inhibits Caspases by Oxidation of the Catalytic Cysteine.

Authors:  Prateep Pakavathkumar; Gyanesh Sharma; Vikas Kaushal; Bénédicte Foveau; Andrea C LeBlanc
Journal:  Sci Rep       Date:  2015-09-24       Impact factor: 4.379

10.  In Silico Insight into Potent of Anthocyanin Regulation of FKBP52 to Prevent Alzheimer's Disease.

Authors:  Tzu-Chieh Hung; Tung-Ti Chang; Ming-Jen Fan; Cheng-Chun Lee; Calvin Yu-Chian Chen
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-12       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.